193 related articles for article (PubMed ID: 26223652)
1. MicroRNAs miR-155 and miR-16 Decrease AID and E47 in B Cells from Elderly Individuals.
Frasca D; Diaz A; Romero M; Ferracci F; Blomberg BB
J Immunol; 2015 Sep; 195(5):2134-40. PubMed ID: 26223652
[TBL] [Abstract][Full Text] [Related]
2. E47 retroviral rescue of intrinsic B-cell defects in senescent mice.
Landin AM; Frasca D; Harrison P; Scallan M; Riley RL; Blomberg BB
Aging Cell; 2011 Apr; 10(2):327-37. PubMed ID: 21241451
[TBL] [Abstract][Full Text] [Related]
3. Aging down-regulates the transcription factor E2A, activation-induced cytidine deaminase, and Ig class switch in human B cells.
Frasca D; Landin AM; Lechner SC; Ryan JG; Schwartz R; Riley RL; Blomberg BB
J Immunol; 2008 Apr; 180(8):5283-90. PubMed ID: 18390709
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-155 is a negative regulator of activation-induced cytidine deaminase.
Teng G; Hakimpour P; Landgraf P; Rice A; Tuschl T; Casellas R; Papavasiliou FN
Immunity; 2008 May; 28(5):621-9. PubMed ID: 18450484
[TBL] [Abstract][Full Text] [Related]
5. A molecular mechanism for TNF-α-mediated downregulation of B cell responses.
Frasca D; Romero M; Diaz A; Alter-Wolf S; Ratliff M; Landin AM; Riley RL; Blomberg BB
J Immunol; 2012 Jan; 188(1):279-86. PubMed ID: 22116831
[TBL] [Abstract][Full Text] [Related]
6. Repression of human activation induced cytidine deaminase by miR-93 and miR-155.
Borchert GM; Holton NW; Larson ED
BMC Cancer; 2011 Aug; 11():347. PubMed ID: 21831295
[TBL] [Abstract][Full Text] [Related]
7. Downregulated expression of miR-155, miR-17, and miR-181b, and upregulated expression of activation-induced cytidine deaminase and interferon-α in PBMCs from patients with SLE.
Kaga H; Komatsuda A; Omokawa A; Ito M; Teshima K; Tagawa H; Sawada K; Wakui H
Mod Rheumatol; 2015; 25(6):865-70. PubMed ID: 25775145
[TBL] [Abstract][Full Text] [Related]
8. miR-29b directly targets activation-induced cytidine deaminase in human B cells and can limit its inappropriate expression in naïve B cells.
Recaldin T; Hobson PS; Mann EH; Ramadani F; Cousins DJ; Lavender P; Fear DJ
Mol Immunol; 2018 Sep; 101():419-428. PubMed ID: 30081328
[TBL] [Abstract][Full Text] [Related]
9. Histone deacetylase inhibitors upregulate B cell microRNAs that silence AID and Blimp-1 expression for epigenetic modulation of antibody and autoantibody responses.
White CA; Pone EJ; Lam T; Tat C; Hayama KL; Li G; Zan H; Casali P
J Immunol; 2014 Dec; 193(12):5933-50. PubMed ID: 25392531
[TBL] [Abstract][Full Text] [Related]
10. miR-181b negatively regulates activation-induced cytidine deaminase in B cells.
de Yébenes VG; Belver L; Pisano DG; González S; Villasante A; Croce C; He L; Ramiro AR
J Exp Med; 2008 Sep; 205(10):2199-206. PubMed ID: 18762567
[TBL] [Abstract][Full Text] [Related]
11. Estrogen Reverses HDAC Inhibitor-Mediated Repression of
Casali P; Shen T; Xu Y; Qiu Z; Chupp DP; Im J; Xu Z; Zan H
Front Immunol; 2020; 11():491. PubMed ID: 32265934
[TBL] [Abstract][Full Text] [Related]
12. Aging murine B cells have decreased class switch induced by anti-CD40 or BAFF.
Frasca D; Riley RL; Blomberg BB
Exp Gerontol; 2007 Mar; 42(3):192-203. PubMed ID: 17067770
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-155 suppresses activation-induced cytidine deaminase-mediated Myc-Igh translocation.
Dorsett Y; McBride KM; Jankovic M; Gazumyan A; Thai TH; Robbiani DF; Di Virgilio M; Reina San-Martin B; Heidkamp G; Schwickert TA; Eisenreich T; Rajewsky K; Nussenzweig MC
Immunity; 2008 May; 28(5):630-8. PubMed ID: 18455451
[TBL] [Abstract][Full Text] [Related]
14. Effects of aging on B cell function.
Frasca D; Blomberg BB
Curr Opin Immunol; 2009 Aug; 21(4):425-30. PubMed ID: 19608393
[TBL] [Abstract][Full Text] [Related]
15. Activation-induced cytidine deaminase splicing patterns in chronic lymphocytic leukemia.
Marantidou F; Dagklis A; Stalika E; Korkolopoulou P; Saetta A; Anagnostopoulos A; Laoutaris N; Stamatopoulos K; Belessi C; Scouras Z; Patsouris E
Blood Cells Mol Dis; 2010 Apr; 44(4):262-7. PubMed ID: 20117026
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-146a targets PRKCE to modulate papillary thyroid tumor development.
Zhang X; Li D; Li M; Ye M; Ding L; Cai H; Fu D; Lv Z
Int J Cancer; 2014 Jan; 134(2):257-67. PubMed ID: 23457043
[TBL] [Abstract][Full Text] [Related]
17. Tristetraprolin, a negative regulator of mRNA stability, is increased in old B cells and is involved in the degradation of E47 mRNA.
Frasca D; Landin AM; Alvarez JP; Blackshear PJ; Riley RL; Blomberg BB
J Immunol; 2007 Jul; 179(2):918-27. PubMed ID: 17617583
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-381 represses ID1 and is deregulated in lung adenocarcinoma.
Rothschild SI; Tschan MP; Jaggi R; Fey MF; Gugger M; Gautschi O
J Thorac Oncol; 2012 Jul; 7(7):1069-77. PubMed ID: 22592211
[TBL] [Abstract][Full Text] [Related]
19. miR-495 is upregulated by E12/E47 in breast cancer stem cells, and promotes oncogenesis and hypoxia resistance via downregulation of E-cadherin and REDD1.
Hwang-Verslues WW; Chang PH; Wei PC; Yang CY; Huang CK; Kuo WH; Shew JY; Chang KJ; Lee EY; Lee WH
Oncogene; 2011 May; 30(21):2463-74. PubMed ID: 21258409
[TBL] [Abstract][Full Text] [Related]
20. MiR-9 downregulates CDX2 expression in gastric cancer cells.
Rotkrua P; Akiyama Y; Hashimoto Y; Otsubo T; Yuasa Y
Int J Cancer; 2011 Dec; 129(11):2611-20. PubMed ID: 21225631
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
